Log in to save to my catalogue

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2622289027

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

About this item

Full title

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2022-03, Vol.603 (7902), p.693-699

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The Omicron (B.1.1.529) variant of SARS-CoV-2 emerged in November 2021 and is rapidly spreading among the human population
1
. Although recent reports reveal that the Omicron variant robustly escapes vaccine-associated and therapeutic neutralization antibodies
2

10
, the pathogenicity of the virus remains unknown. Here we show t...

Alternative Titles

Full title

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2622289027

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2622289027

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-022-04442-5

How to access this item